CLL.L Share News (CLL)

CLL.L Information

There is currently no data for CLL

Cello Health Secures 11% Holding In Access Intelligence

Mon, 07th Oct 2019 15:23

(Alliance News) - Marketing software services firm Access Intelligence on Monday said Cello Health PLC has built an 11% stake in the company.

The healthcare-focused advisory firm's holding in Access Intelligence prior to Monday's transaction was not stated.

On Wednesday, Cello Health said it sold its social media analytics software business Pulsar to Access Intelligence PLC for GBP4.5 million in shares.

As part of the terms of the deal, Access Intelligence will issue to Cello 8.7 million shares plus a nominal payment.

Shares in Access Intelligence were untraded in London on Monday afternoon, last quoted at 53.00 pence each and Cello Health's stock was trading 1.2% higher at 128.00p each.

By Eric Cunha; ericcunha@alliancenews.com

More News

16 Mar 2010 14:49

London afternoon: G4S locked out of market rally

The Footsie stopped just short of dipping into negative territory over the lunchtime session before buyers moved back in just before 2pm. Banks and miners continue to provide many of the bright spots, with the latter benefitting from higher metal prices. In banking, Royal Bank of Scotland is want

16 Mar 2010 12:03

London midday: Early gains trimmed

The FTSE 100 was clinging on to positive territory at the start of the lunchtime session after share prices went into a late morning swoon. Banks and miners continue to provide most of the bright spots, with the latter benefitting from higher metal prices. In banking, Royal Bank of Scotland is wa

16 Mar 2010 09:05

Cello profit shrinks, ups divi

Shares in marketing services group Cello surged 9% as it said 2009 profit fell as clients cut spending but trading since the start of 2010 has been good. Headline pre-tax profit fell to £5.1m for the year to 31 December 2009 from £7.3m the year before. Revenue from continuing operations dropped 8%

19 Jan 2010 08:44

Cello says activity picking up, remains cautious

Cello, a marketing services group, said it is seeing refreshed levels of spend across its major research clients but remains cautious about the current outlook. Shares in the group rose nearly 2%. "Whilst the board remains realistically cautious about the current outlook and it is too early to give

15 Sep 2009 13:52

Small caps round-up: China Shoto, Resources in Insurance, Cello...

Continued growth in the Chinese economy despite the global downturn helped China Shoto, which makes batteries for mobile phones, post a 41% rise in revenues in the half year to June 30. Pre-tax profits climbed to £6.4m from £4.4m over the same period the previous year as revenue rose to £96.5m from

3 Jul 2009 07:50

Cello cuts costs to offset slowdown

A slowdown at its qualitative research business has prompted Cello to caution like for like gross profits are down by around 10% year on year, with operating margins also squeezed. The market research group has cut costs to offset the downturn. Like for like professional costs have been reduced by

Latest Share Chat

CLL.L Share News (CLL)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cello Health Secures 11% Holding In Access Intelligence

London afternoon: G4S locked out of market rally

London midday: Early gains trimmed

Cello profit shrinks, ups divi

Cello says activity picking up, remains cautious

Small caps round-up: China Shoto, Resources in Insurance, Cello...

Cello cuts costs to offset slowdown

Login to your account

Quickpicks are a member only feature

Login to your account